跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial. - TGA Drug Approval Details
Approvals
/
TGA
/
OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial.
Approved
STANDARD
OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial.
Medison Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e4c099f7d26e6282
Company
Medison Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e4c099f7d26e6282
Product Name
OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial.
Artg Id
421050
Artg Name
OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial.
Sponsor
Medison Pharma Australia Pty Ltd
Company Detail Path
/organization/medison-pharma-australia-pty-ltd
Artg Date
2024-06-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e4c099f7d26e6282
Type
Standard
Back to TGA Approvals
